Press Release 04 June 2025 White & Case advises Noteus Partners and Sofina on investment in Scalable Capital´s equity financing round
Press Release 15 May 2025 White & Case advises Samsung Electronics on €1.5 billion acquisition of German FläktGroup
Press Release 11 April 2025 White & Case advises lending platform Teylor on acquisition of Grenke’s factoring division
Press Release 30 August 2024 White & Case advises Groupe BPCE on acquisition of Société Générale Equipment Finance
Press Release 06 August 2024 White & Case advises Pollen Street Capital on intended acquisition of Etops Group
Press Release 29 February 2024 White & Case advises ENVIRIA on capital commitment of over US$200 million from BlackRock
Press Release 03 January 2024 White & Case advises Enpal on Equitix and Keppel’s majority stake in one of Enpal’s energy system portfolios
Press Release 30 October 2023 White & Case advises Pollen Street Capital on multi-layered investments in niiio finance group
Press Release 28 November 2022 White & Case advises Adler Group on comprehensive recapitalisation and amendment of bond terms
Press Release 11 October 2022 White & Case advises Pollen Street Capital on acquisition of majority shareholding in Pair Finance
Press Release 26 January 2022 White & Case advises Landesbank Baden-Württemberg on acquisition of Berlin Hyp
Press Release 13 January 2022 White & Case advises Adler Group on €1.05 billion residential portfolio sale and reduction of debt ratio
Press Release 10 December 2021 White & Case advises Adler Group on sale of €1.3 billion Real Estate portfolio to LEG
Press Release 09 July 2021 White & Case Advises Nestlé Health Science on Acquisition of Mevalia and Comidamed Brands
Press Release 21 January 2021 White & Case Advises Memsource and The Carlyle Group on Acquisition of Majority Stake in Phrase
Press Release 15 January 2021 White & Case Advises CORESTATE on Acquisition of Aggregate Financial Services
Press Release 11 September 2020 White & Case Advises Takeda on Agreement to Divest Select Non-core European Assets to Cheplapharm for Approximately US$562 Million
